Once POET gets full exposure, it will sell itself and this will be as much because of Dr. Taylor's genius as Peter Copetti's drive for market adoption. I say he takes a short breather to enjoy some of the fruits of his efforts but stays on the BOD to see the company through to many more developments adhering to the new tenets of POET's Law for the next couple of decades.